{"name":"Astria Therapeutics, Inc.","slug":"astria-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNTFFFVUVvWTVWRGRXdDBSZWpPXzhXMnJFSlRfZWlNcVN2NzVuZzh4aUJ0MHB1X0lpNHhBdjQyWF9YcTVCWjBhalR2RU5XdC03cERMeU1HZFh2MDlENXE0LTlhMm56QW12MGF4a0xKSmV5eVJxa0tOOHppcTd2NzFqY2xuUjBFMVpXcW9jZ3RRRVRDeWxXVy0tdVZKeVUyLXR1OTFTQmtaNWJkeXg0SFpUSkR1dThfZURzUjF3VF9YZVdmV3lsaXBOcVQxZlI2VmZGM2dYN2hvcWtaRFRLQzVGWVk4WDktU0dTdmdHZV85WVBfQTNPLTdDdlhySE9LV0RD?oc=5","date":"2026-02-26","type":"deal","source":"TradingView","summary":"BCRX: $400M Blackstone term loan funds Astria deal, secured by assets, matures 2031, SOFR+4.5% - TradingView","headline":"BCRX: $400M Blackstone term loan funds Astria deal, secured by assets, matures 2031, SOFR+4.5%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBCRTZzMkUwd2tGTld1SEJWZy1SZ3dENk8temVrT0IxVVBjYmxtUUVNRFZBcWsySXpFcXBiWDM1aXRQSmFUYTViSnNOdDlnYW50TUtoWTJudmhNTTJJTElDSG1KN2k5ekVUclAzQmRlX2lOV3dzX1ZiVkUxMk9TZw?oc=5","date":"2026-02-23","type":"pipeline","source":"Yahoo Finance","summary":"Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition - Yahoo Finance","headline":"Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQa3FKRXNlZzhUcURDTDM4ZGp5RlhNVGljNEpZQzNoTHdxQ0tpaUFwRC1fNDItQ1RuR2xiZ2ltT3pxQ0g1akx4QmFBa0dsWEswOWRmT1NFa0JsS1plRmRrdUNJLVltX3JlZDVkMF9EUXBvRE9aS1BCQWN4bG1TTVNSS2VoZUZGTXlwX1FvcE9ScWNaM0U5bnM4c0dYX0JVWl9lWE40YXVXekZDNTVTX2FmaXUtSXA0N1d0Ujl2ajJteF9ZTExiRXhSbC00VHptOXhBUlZuRlVUN3J4QzRWR19NX0VReEFpWlRRVEVWX0J3ckRZbGdCSW9mRXpkTFkzQVdTT3dZRktB?oc=5","date":"2026-01-23","type":"regulatory","source":"GlobeNewswire","summary":"BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema - GlobeNewswire","headline":"BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNaGZ1ZVB4WFNsRTMzYWlwbkpDMTlyWThJOF9OMG9mZlNLM0ZRaURmV2tGZTlkam56aHhndDJxZ283RVhFczJlSEMwUEZHamNlUk5LUGFZLUZjVld0bENXNTNIbFJGMVhYYWtMS1BkUXR2N2puZDFiZi10eFpSTGdqRUp0T05iOXBCMk9uc25aaXJYR2lBbVIyUVRIQnd0WEY1YXpLLVk4elBMNWJNMVlTa29HaXpwSDViMTNFTzJLMA?oc=5","date":"2026-01-23","type":"pipeline","source":"Investing.com","summary":"BioCryst completes $700 million acquisition of Astria Therapeutics - Investing.com","headline":"BioCryst completes $700 million acquisition of Astria Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQU2k4alFnbVlJQVJMR2E3WmZzZlpIZmZQWlpFellwcllfUWRuT2JKOXItTGF3d3RuT1hGMXQ1bkpieFI1NElibFpDcnVSYUY4MFJtTnBUOURaVHVIaGs0QXpOQjRvMWhDN3Q3bEU1V2xZV2pQeWV4eURVMHNiUzdiSU12a0xrc1hta3RhVGZ3OUxhUHRpZGRLRFJzVFRZZndqZDhqTHQ3alh6aWU4elpubkV6bkE3amVsVWVQaUY4cVlNbEp2SlE?oc=5","date":"2026-01-23","type":"pipeline","source":"Quiver Quantitative","summary":"BioCryst Pharmaceuticals Completes Acquisition of Astria Therapeutics to Enhance HAE Portfolio | BCRX Stock News - Quiver Quantitative","headline":"BioCryst Pharmaceuticals Completes Acquisition of Astria Therapeutics to Enhance HAE Portfolio | BCRX Stock News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNU2dwdFJFSk5UNXZ4OHpZd2cwMk9BRXJTSWRELWNtVE9fU0ctSDJMNU04LS1wNVpyNVNlQy1LTmw3NzFlX0Fmakx2R2ZwR1cxVE5KRW5lZnNhZnVpQ3RsTEkxOXVRT3FzTUhuM0RqZHdQQk0zRjlPTDJPUUV5bWZiZ2JCMjN1Y0FMa3BiY2VQa1U5dUVERGg1NHhodkNMVzREdWh6aHV1aVBmdWk1bzJEUjN2V2wzazA?oc=5","date":"2026-01-21","type":"regulatory","source":"businesswire.com","summary":"Astria Stockholders Vote to Approve Acquisition by BioCryst - businesswire.com","headline":"Astria Stockholders Vote to Approve Acquisition by BioCryst","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxQT3hZdXV4elUzemM4NW1Ccml6NDJNeDRmaTZySnRUXzZBWk9rVWRCZEhZbHo5U28zaHNoQzRNOC1SeThib01VUDRNNXlmNVI5cVVfSDFIVlhyVWlpLXZFX090OTg0WlZBWjY1YlZTWWw3Z0hFQVl4NGJZOGdJOG9CYklkRFB3Umswa29ST2RNNXVNT0d5OVFtOWRyN3VJSlAtejJLa0R1djNUNGlHMU9xSy1LR3BEd3VOLVEycGRsQ1Jyazd0N1V0cEdNckJ5dmZCNnd4c0pnS2ZUd28?oc=5","date":"2025-12-03","type":"pipeline","source":"Quiver Quantitative","summary":"BioCryst Pharmaceuticals Announces Early Termination of HSR Waiting Period for Astria Therapeutics Acquisition - Quiver Quantitative","headline":"BioCryst Pharmaceuticals Announces Early Termination of HSR Waiting Period for Astria Therapeutics Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9aVGNNNHk0aUF5dVFSWlQ2S2todnJsR2dYUjdWWGJha2Rlb202NDFDQko5ZTFla2Vydm1fbmY4ZW1TY1lldVZjVTJ3blZpeWNlak1tZERLd24tZDg3SnJRcFhITUJMWElxeWw0MTA3elJCSzI0ZGgw?oc=5","date":"2025-10-15","type":"deal","source":"Pharmaceutical Technology","summary":"BioCryst to buy Astria Therapeutics for $700m in enterprise value - Pharmaceutical Technology","headline":"BioCryst to buy Astria Therapeutics for $700m in enterprise value","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPcUdZMmlPblJRU3U2ZzYxYVpid0FxbU9GblJkLTF3TGlTY2pWVkF2dDUzTjhSd2k0Ym5yaUhmMEZ0aktwd2F0QlpWUmU5MjgyMGppeDZ2cDZIQ2JQMHF4Wkd5V3ZKd2drc29KZlRXcnI1WVZkQXFldnpveDUzcF9ENXpQZndpNGhxYl9pSlRCZGJxNTBhQzBlOTVQS2Y5eFk?oc=5","date":"2025-10-15","type":"deal","source":"finviz.com","summary":"Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX - finviz.com","headline":"Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQX1dwQ09tSzhidGpFcVl6R2dOc3VEcXZKT1RXNFFybjVPVnQ4UW9NWkY2VC1qRG4xUHQ2dTg4dmo4MmFiS3RLS0hyQmpfbXJvN0t0MHBDNEdmTFpXbVBVUUc0dXJhTDdIb014OWVNTW5qUnpsN2Qxc19wZHdjeldfRHNUdXN6dmpPVlpNanhHdC0wMGZJZ1VNeDJrZUJDMUZaUmtDWE5NR2g?oc=5","date":"2025-10-14","type":"deal","source":"Contract Pharma","summary":"BioCryst to Acquire Astria Therapeutics in $700 Million Deal - Contract Pharma","headline":"BioCryst to Acquire Astria Therapeutics in $700 Million Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbFZNbXJ0dlhDaEZ5M1lDaEZoNkJOV2FiNnlsQk03ZDhBOXJRb2g3MEZpQWlhbGtVNnk5Uk5nUDYwVzZmdmRVNXJFdTE1WXo0SGZFNTVUZFVOVUJTNGFTb2xEd0doaFhsMVBfS3ZMaEVKVmx3NEFFUHB3MUdWU25CVHRnOEJpZUU0R3JPeWFoWS10NF9oZFg4V0xlZ0tuVEJLNk1vbTNMUmQ?oc=5","date":"2025-10-14","type":"deal","source":"Reuters","summary":"BioCryst deepens rare diseases focus with $700 million deal for Astria - Reuters","headline":"BioCryst deepens rare diseases focus with $700 million deal for Astria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNV2NiTzB2blpwSkJjM1FrbUhGcThXUF9rMWVjTFBlc0lYTUVhb2hQb20zUjB1Mkhaa1kzalE4QUU4ckdBa3hwR3duZmIyLVhpTG50djVnUWJGNEhFVTRjZ0o1VzJDdUtPVWNjQnBlU294Q2tpOGR3RXhRSmNzSUxVb2JzNnpoMkZlVVk4SGloaWg0RDFVNnhzTU9tU2N4X3J4bXRoeW15UzFSeXlXX1BMR2V0MmJSR1M1WkstVnJkVl8xdkdaMzBlVC02ZHdXUQ?oc=5","date":"2025-10-14","type":"pipeline","source":"Benzinga","summary":"Why Is BioCryst Pharmaceuticals Stock Trading Lower Today? - BioCryst Pharma (NASDAQ:BCRX) - Benzinga","headline":"Why Is BioCryst Pharmaceuticals Stock Trading Lower Today? - BioCryst Pharma (NASDAQ:BCRX)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}